Delta 9 Cannabis Inc. engages in the production and sale of medical cannabis products. Its products include strains, clones, and LP starting materials. The company also operates a medical clinic that provides physician consultation services to patients seeking a medical recommendation. In addition, the company offers integra boost for preserving the smell of the flowers. Delta 9 Cannabis Inc. is based in Vancouver, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$2.60 million
Profitability
Miscellaneous
Employees79
Next Earnings DateN/A
OptionableOptionable
Delta 9 Cannabis (CVE:NINE) Frequently Asked Questions
What is Delta 9 Cannabis' stock symbol?
Delta 9 Cannabis trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NINE."
Has Delta 9 Cannabis been receiving favorable news coverage?
News stories about NINE stock have been trending somewhat positive this week, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Delta 9 Cannabis earned a media sentiment score of 0.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days.
Who are some of Delta 9 Cannabis' key competitors?
Some companies that are related to Delta 9 Cannabis include HLS Therapeutics (HLS), Depomed (ASRT), ICC Labs (ICC), Zomedica Pharmaceuticals (ZOM), WeedMD (WMD), Biosyent (RX), Probiotec (PBP), Invion (IVX), Viridium Pacific Group (VIR), MMJ Group (MMJ), Cipher Pharmaceuticals (CPH), Indiva (NDVA), MGC Pharmaceuticals (MXC), ESSA Pharma (EPI) and Acerus Pharmaceuticals (ASP).
What other stocks do shareholders of Delta 9 Cannabis own?
Who are Delta 9 Cannabis' key executives?
Delta 9 Cannabis' management team includes the folowing people:
- Mr. John William Arbuthnot IV, CEO & Director (Age 29)
- Mr. John William Arbuthnot III, Chairman & Pres (Age 65)
- Mr. Jim Lawson, Interim CFO & Controller
- Mr. Gary Symons, Director of Communications
How do I buy shares of Delta 9 Cannabis?
Shares of NINE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Delta 9 Cannabis' stock price today?
One share of NINE stock can currently be purchased for approximately C$1.47.
How big of a company is Delta 9 Cannabis?
Delta 9 Cannabis has a market capitalization of C$125.75 million and generates C$2.60 million in revenue each year. Delta 9 Cannabis employs 79 workers across the globe.
What is Delta 9 Cannabis' official website?
MarketBeat Community Rating for Delta 9 Cannabis (CVE NINE)
MarketBeat's community ratings are surveys of what our community members think about Delta 9 Cannabis and other stocks. Vote "Outperform" if you believe NINE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NINE will underperform the S&P 500 over the long term. You may vote once every thirty days.
